JNJ · Johnson & Johnson · Executive Compensation
$271.60
+1.38 (+0.51%)
At close · Sep 18
Market Cap
$641.80B
Shares
2.41B
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| J. Duato | Chairman/CEO | $32,758,111 |
| J. Wolk | EVP, CFO | $14,405,442 |
| J. Taubert | EVP, WWC Innovative Medicine | $14,030,063 |
| J. Reed | EVP, Innovative Medicine, R&D | $12,214,062 |
| T. Schmid | EVP, WWC, MedTech | $9,336,765 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| J. Duato | Chairman/CEO | $24,302,360 |
| J. Wolk | EVP, CFO | $12,617,568 |
| T. Schmid | EVP, WWC, MedTech | $11,862,938 |
| J. Taubert | EVP, WWC Innovative Medicine | $11,190,045 |
| J. Reed | EVP, Innovative Medicine, R&D | $9,304,430 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| J. Duato | Chairman/CEO | $13,099,487 |
| J. Wolk | EVP, CFO | $8,823,082 |
| J. Taubert | EVP, WWC Innovative Medicine | $8,781,532 |
| A. McEvoy | Former EVP, WWC MedTech | $7,390,161 |
| T. Mongon | EVP, Worldwide Chair Consumer Health | $7,092,410 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Alex Gorsky | Chairman/CEO | $26,741,959 |
| Paulus Stoffels | VC of the Executive Committee, CSO | $15,007,450 |
| Joaquin Duato | Vice Chairman of the Executive Committee | $13,805,292 |
| J. Duato | Chairman/CEO | $13,805,292 |
| Joseph Wolk | EVP, CFO | $10,953,615 |
| J. Wolk | EVP, CFO | $10,953,615 |
| Jennifer Taubert | EVP, Worldwide Chair Pharmaceuticals | $10,225,759 |
| J. Taubert | EVP, WWC Innovative Medicine | $10,225,759 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Alex Gorsky | Chairman/CEO | $29,575,974 |
| Paulus Stoffels | VC of the Executive Committee, CSO | $16,439,968 |
| Joaquin Duato | Vice Chairman of the Executive Committee | $15,625,003 |
| J. Duato | Chairman/CEO | $15,625,003 |
| J. Wolk | EVP, CFO | $10,196,038 |
| Joseph Wolk | EVP, CFO | $10,196,038 |
| Jennifer Taubert | EVP, Worldwide Chair Pharmaceuticals | $9,532,469 |
| J. Taubert | EVP, Worldwide Chair Pharmaceuticals | $9,532,469 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Alex Gorsky | Chairman/CEO | $25,365,777 |
| Paulus Stoffels | VC of the Executive Committee, CSO | $14,067,849 |
| Joaquin Duato | Vice Chairman of the Executive Committee | $13,419,302 |
| Joseph Wolk | EVP, CFO | $7,497,692 |
| Jennifer Taubert | EVP, Worldwide Chair Pharmaceuticals | $7,097,300 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Alex Gorsky | Chairman/CEO | $20,097,572 |
| Paulus Stoffels | VC of the Executive Committee, CSO | $10,591,765 |
| Joaquin Duato | Vice Chairman of the Executive Committee | $9,283,960 |
| Joseph Wolk | EVP, CFO | $2,708,189 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Alex Gorsky | Chairman/CEO | $29,802,564 |
| Joaquin Duato | Vice Chairman of the Executive Committee | $19,359,308 |
| Paulus Stoffels | VC of the Executive Committee, CSO | $13,580,786 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Tom Cavanaugh | Executive Vice President, Worldwide Chairman, Innovative Medicine | Appointed | 2026-08-04 |
| Jennifer Taubert | Executive Vice President, Worldwide Chairman, Innovative Medicine | Retired | 2026-08-04 |
| John Morikis | Board of Directors | Appointed | 2025-09-09 |
| Daniel Pinto | Board of Directors | Appointed | 2025-06-10 |
| D. Adamczyk | Board of Directors | Retired | 2025-04-30 |
| D. S. Davis | Director | Retired | 2024-09-10 |
| Kristen Mulholland | Chief Human Resources Officer | Appointed | 2024-08-26 |
| Peter M. Fasolo | Executive Vice President, Chief Human Resources Officer | Retired | 2024-08-26 |
| Eugene A. Woods | Board of Directors | Appointed | 2023-12-05 |
| Tim Schmid | Executive Vice President, Worldwide Chairman of MedTech | Appointed | 2023-10-23 |
| Ashley McEvoy | Executive Vice President, Worldwide Chair MedTech and member of the Executive Committee | Resigned | 2023-10-23 |
Key facts
CIK
200406
CUSIP
478160104
13F (30d)
155 filings
78 filers
Visit website
Investor relations